Rick Simpson Oil (RSO) in Fulton County, Illinois: The Complete Guide by OilWell Cannabis

If you’re reading this from Lewistown, Canton, Farmington, or anywhere across Fulton County’s rolling farmland, you’ve probably heard whispers about Rick Simpson Oil. Maybe you overheard someone at the Grainery in Canton talking about cannabis oil for their cancer treatments. Maybe a neighbor down a gravel road near Fiatt mentioned it helped with their chronic back pain after years of farm work. Or perhaps you’re a veteran in Spoon River territory who learned about RSO through a friend at the American Legion. However you found your way here, you’re looking for honest answers about this controversial cannabis extract — and more importantly, you’re wondering where in Fulton County you can actually get it.

Here’s the truth: Fulton County is what we call a “cannabis desert.” You won’t find RSO at the pharmacy in Lewistown. There’s no dispensary on Main Street in Cuba. The nearest legal cannabis dispensary is at least 40 miles away in Peoria or Galesburg — a significant journey for someone battling cancer, managing severe chronic pain, or struggling with the kinds of PTSD that keep too many of our veterans awake at night. We know because we serve Fulton County residents every day, shipping directly to your doorstep from our Houston hub. We understand that in a county where the median income is below the state average and where agricultural workers face daily exposure to chemicals that can lead to cancer and chronic illness, accessibility isn’t just a convenience — it’s a lifeline.

This guide is written specifically for you — the Fulton County resident who needs complete, unfiltered information about RSO. We’ll tell you the real history of Rick Simpson (who he actually was, what he actually did, and what the science actually says). We’ll share our own story — how a guy who grew up in one of Texas’s most dangerous border towns, who lost friends to violence and prison, who saved his paralyzed dog Bentley with a cannabis formula, and who personally fought benzodiazepine addiction using the same cannabinoid knowledge that now informs our RSO — built this company from nothing but desperation and love. We’ll show you our exact formulas (every milligram, every percentage), explain our rigorous testing, and demonstrate why our approach solves the problems that made traditional RSO both revolutionary and dangerous.

Most importantly, we’re not going to sell you false hope. We’re not doctors. We’re not here to tell you RSO will cure your cancer. What we are is a team of formulation experts who believe you deserve the best possible version of cannabis education so you can make informed decisions for yourself and your family. In Fulton County, where healthcare access is limited and trust in institutions is understandably shaky, that kind of honesty matters more than ever.

Understanding Rick Simpson Oil: The Real Story

Who Was Rick Simpson?

Rick Simpson was born in 1949 in Amherst, Nova Scotia, Canada — a small town not unlike some of Fulton County’s communities. He wasn’t a doctor. He wasn’t a scientist. He was a power engineer and maintenance worker, a blue-collar tradesman whose path into cannabis advocacy began not in a lab but in personal suffering. In 1997, while working at a hospital in Moncton, New Brunswick, Simpson fell from scaffolding and suffered a serious head injury. The aftermath included persistent tinnitus, dizziness, and post-concussion symptoms that conventional medicine couldn’t resolve.

Sound familiar? We meet Fulton County residents every week who’ve been through similar cycles — the workplace injury at the grain elevator in Smithfield, the chronic pain from decades on a combine in Putman, the post-concussion issues from a tractor rollover near Norris. These folks tell us the same story Simpson lived: medications that failed to help or made things worse, doctors who refused to consider alternatives, and a growing desperation for relief.

When Simpson asked his physician about cannabis, the doctor refused. So Simpson took matters into his own hands. He learned about a 1974 NIH-funded study at the Medical College of Virginia that reported THC could slow or shrink tumors in mice. That study — intended to demonstrate harm, not benefit — became Simpson’s North Star, even though its findings were never replicated in controlled human cancer trials.

The Moment That Started a Movement

In 2003, Simpson noticed three bumps on his arm that his doctor diagnosed as basal cell carcinoma. Rather than pursuing conventional treatment, Simpson applied concentrated cannabis oil directly to the lesions, covered them with bandages, and waited. According to his account, the bumps disappeared within four days. No biopsy confirmation. No independent medical verification. No peer-reviewed documentation. Just one man’s personal experience that became the origin story of Rick Simpson Oil.

Important Context for Fulton County Residents: We present Simpson’s account as personal testimony, not medical evidence. The absence of clinical documentation means these events cannot be evaluated as scientific proof. However, they are historically significant as the catalyst for a global movement. In Fulton County, where word-of-mouth and personal testimonials carry weight in tight-knit communities, we understand why stories like this resonate. But we also know that cancer is too serious to treat based on anecdotes alone. That’s why later in this guide, we’ll show you what the actual scientific evidence says — and doesn’t say — about cannabis and cancer.

The Crusade: Spreading the Oil

After his 2003 experience, Simpson committed himself to producing and distributing concentrated cannabis oil. Operating from his property in Maccan, Nova Scotia, he began making oil in large quantities and giving it away for free to cancer patients and others in his community. He charged nothing. By his account, he helped dozens of people with conditions including cancer, chronic pain, diabetes, infections, glaucoma, arthritis, depression, insomnia, and more.

Simpson’s story reached a global audience through the 2005 documentary Run From The Cure, directed by Christian Laurette. The film documented Simpson’s claims, showed testimonials, and framed his work as a grassroots challenge to pharmaceutical interests. Distributed freely online, it became one of the most widely shared cannabis advocacy films of its era. For many in Fulton County who first heard about RSO through YouTube or Facebook, this documentary was their introduction.

Legal Conflict and Exile

Simpson’s advocacy brought him into direct conflict with Canadian law. The Royal Canadian Mounted Police raided his property in 2005 and 2009, seizing plants and equipment. He was charged with cultivation, possession, and trafficking. Facing continued legal pressure, Simpson eventually left Canada for Europe, living in Croatia and later the Netherlands, where he continued his advocacy from abroad.

In 2012, he published Phoenix Tears: The Rick Simpson Story and maintained phoenixtears.ca as his advocacy platform. Throughout his career, Simpson maintained that cannabis oil could cure cancer and that pharmaceutical companies, government agencies, and medical institutions were actively suppressing this knowledge.

What This Means for Fulton County: The cannabis landscape has changed dramatically since Simpson’s era. Illinois legalized recreational cannabis in 2020, and while Fulton County still lacks local dispensaries, the legal framework exists. Simpson operated illegally; we operate legally under the 2018 Farm Bill. That evolution matters — it means Fulton County residents can access RSO without the legal risks Simpson faced, provided they obtain it from compliant sources like OilWell.

The Traditional RSO Protocol: What Simpson Actually Recommended

Simpson’s core treatment recommendation was a structured oral protocol designed to deliver 60 grams of concentrated cannabis oil over approximately 90 days. Many Fulton County residents encountering RSO for the first time find this protocol online and wonder if they should follow it. Here’s exactly what Simpson recommended, with the critical context you need to evaluate it safely.

The 60-Gram Goal

Consume 60 grams (approximately 60 mL) of concentrated, high-THC cannabis oil over about 90 days. Simpson considered this the minimum necessary for serious cancer treatment.

Titration Schedule

Week 1: Begin with a dose the size of half a grain of dry rice — roughly 10-15 milligrams of oil — taken three times daily (morning, afternoon, before bed). Total daily intake: approximately 30-45 milligrams.

Weeks 2-5: Double the dose approximately every four days. The slow ramp-up was meant to build THC tolerance gradually. By the end of this period, the target is approximately 1 gram (1,000 milligrams) of oil per day, divided into three roughly equal doses of 333 milligrams each.

Weeks 5-12: Maintain the full dose of approximately 1 gram per day until all 60 grams are consumed.

Administration Methods

• Oral (Primary): Place the dose under the tongue or swallow it. Simpson considered this the most important route for systemic absorption.
• Topical (Secondary): Apply directly to skin cancers and lesions, covering with a bandage changed every 3-4 days.
• Inhalation (Not Recommended as Primary): Simpson acknowledged inhalation for immediate symptom relief but maintained oral dosing was necessary for sustained therapeutic exposure.

Tolerance and Psychoactive Effects

Simpson maintained that patients develop significant tolerance to THC’s psychoactive effects within 3-4 weeks. He recommended initial nighttime dosing to sleep through the most intense effects and urged patients not to drive or operate machinery during titration.

Post-Protocol Maintenance

After completing the 60-gram course, Simpson recommended a maintenance dose of 1-2 grams per month indefinitely.

Dietary Recommendations

Simpson advocated reducing sugar, avoiding processed foods, and improving overall nutrition, though he wasn’t specific about dietary protocols.

Critical Context for Fulton County Residents

This protocol was designed by one person based on personal experience, not clinical trials. Here are the facts you need to know:

• No Controlled Trial Validation: There are no published randomized controlled trials, cohort studies, or well-documented case series evaluating this specific 60-gram/90-day protocol for any condition.
• Crude, Unstandardized Material: The 60-gram quantity assumes single-strain, THC-dominant extract with no standardized potency. Traditional RSO THC content varied widely.
• Very High THC Exposure: At peak dosing (1 gram per day of 60-90% THC oil), patients consumed approximately 600-900 milligrams of delta-9 THC daily. The FDA-approved synthetic THC drug dronabinol is typically dosed at 2.5-20 milligrams per day.
• Real Risks: Consuming 600-900 mg of THC daily carries serious risks including severe intoxication, anxiety, panic, tachycardia, hypotension, and cannabis use disorder. These risks are well-documented in the scientific literature.
• Oncology Complexity: Patients with active cancer are medically complex. Using unregulated, unstandardized cannabis oil as primary treatment — potentially instead of proven therapies — introduces harm beyond the oil itself.

The Bottom Line for Fulton County: If you’re considering RSO for cancer or any serious condition, please consult with your oncologist at Graham Hospital in Canton or your specialist at UnityPoint in Peoria. RSO should complement, not replace, proven treatments. The 60-gram protocol was designed for a crude product that no longer represents the best available science.

What Traditional RSO Actually Was

Understanding what Simpson actually made is crucial for Fulton County residents who might see “RSO” on a product and assume it’s the same thing. It’s probably not — and that’s often a good thing.

Source Material

Simpson used high-THC, indica-dominant cannabis strains with no standardization. Every batch depended on whatever plant material was available.

Extraction Solvent

Simpson originally used naphtha (petroleum-based lighter fluid) or 99% isopropyl alcohol. Neither is food-grade. Naphtha may contain benzene, toluene, and other toxic compounds. This is one of the most significant safety concerns with traditional RSO.

Extraction Process

The process involved soaking plant material in solvent, filtering, and evaporating the solvent in a rice cooker at temperatures sufficient to decarboxylate THCa into THC and destroy most terpenes. The result was a thick, nearly black, tar-like oil with a strong cannabis and possible solvent-residual odor.

Cannabinoid Profile

Traditional RSO was fully decarboxylated, THC-dominant (60-90% estimated), with minor cannabinoids at natural, uncontrolled ratios. There was no lab testing, no Certificate of Analysis, no cannabinoid quantification.

Terpene Content

Essentially none. The solvent and heat process destroyed the volatile terpenes present in the raw plant.

For Fulton County Residents Considering DIY

We know the DIY spirit runs strong in rural Illinois. Many of you have made your own herbal remedies. But traditional RSO production carries real risks:

• Residual solvents are difficult to verify without lab equipment
• Fire hazard from evaporating flammable solvents
• Inconsistent potency batch to batch
• No contamination screening

If you can’t afford our product, we provide our exact formula later in this guide so you can source safe, lab-tested distillates and make your own version without the dangers of solvent extraction.

Simpson’s Claims vs. The Evidence Record

This is where we separate hope from hype — something especially important for Fulton County residents facing serious health challenges.

What Simpson Claimed

Simpson stated that RSO could cure cancer and was effective against diabetes, chronic pain, infections, glaucoma, arthritis, depression, insomnia, multiple sclerosis, and more. He was absolute and consistent in these claims.

What The Science Actually Shows

Preclinical Literature:

• In vitro studies show THC and CBD can induce apoptosis (programmed cell death), inhibit proliferation, and reduce angiogenesis in certain cancer cell lines.
• Animal models show some tumor-growth inhibition.
• These findings are scientifically interesting but have NOT translated into proven human cancer cures.

What The Preclinical Literature Does NOT Show:

• No human clinical trial has demonstrated that RSO or any cannabis oil preparation cures cancer.
• The gap between lab/animal results and human clinical outcomes is vast and well-documented.
• Small human trials in cancer contexts (particularly glioblastoma) have been exploratory and have not produced results supporting cancer-cure claims.

Institutional Positions:

• National Cancer Institute (NCI): Acknowledges cannabinoids have been studied for potential anticancer effects but does not endorse cannabis as a cancer treatment.
• FDA: Has not approved any cannabis plant product for cancer treatment. Only Epidiolex (CBD for seizures) and synthetic THC analogues for chemo nausea and AIDS wasting are approved.
• Health Canada: Has never approved RSO or cannabis oil as a cancer cure.
• NCCIH: States the strongest cannabinoid evidence is for rare epilepsies, chemo nausea, and HIV/AIDS appetite — not cancer cure.

What Simpson Got Right

Simpson drew attention to cannabinoids as a serious biomedical research area when the world was ignoring it. His advocacy helped create the political and cultural conditions for the legal cannabis industry that now allows us to serve Fulton County residents. The term “RSO” remains the most recognized name for full-spectrum cannabis extract.

What He Overstated

The leap from preclinical signals to cancer cure was never supported by human evidence. Encouraging patients — particularly cancer patients — to rely on RSO as primary treatment instead of proven oncologic therapies carries genuine harm potential. Delayed or foregone treatment for treatable cancers is a documented concern in alternative medicine.

For Fulton County Cancer Patients: We know many of you travel to Peoria’s OSF Saint Francis or UnityPoint for oncology care. Some of you may be considering RSO as an alternative. Please don’t. Use RSO as a complement to your treatment, not a replacement. Talk to your oncologist. The science is clear: no cannabis product has been proven to cure cancer in humans.

The Legacy of Rick Simpson and Modern RSO Evolution

Today, “RSO” has become a generic term. Many products labeled RSO bear little resemblance to Simpson’s original. In legal dispensaries, RSO can refer to almost any full-spectrum extract sold in a syringe.

Simpson himself has criticized commercial products that depart from his method. His model was anti-commercial — give it away free, teach people to make it themselves. The modern industry commercialized what he distributed freely. Whether that’s improvement (quality control, testing) or betrayal (profit, gatekeeping) depends on your perspective.

What isn’t disputed is that modern RSO has evolved substantially. Our formulas are informed by the RSO tradition but depart from it in deliberate, evidence-motivated ways that solve real problems:

Traditional RSO vs. Modern Formulated RSO

Dimension	Traditional RSO	OilWell Formulated RSO
Source material	Single high-THC indica strain	Multi-cannabinoid blend from multiple sources
Extraction method	Naphtha or isopropyl alcohol	Modern food-grade ethanol or CO₂ methods
Cannabinoid profile	THC-dominant, uncontrolled	Seven defined cannabinoids at specific ratios
Terpene content	Destroyed by high-heat process	Live terpenes at 5% with defined seven-terpene profile
Standardization	None — every batch different	Lab-tested with specific mg/mL targets
Lab testing	Not available or performed	Full panel testing
Residual solvents	Significant risk with naphtha	Controlled and tested
Dosing precision	Approximate, syringe-based	Measured per mL with known cannabinoid content (553 mg/mL)
Product formats	Single thick oil only	Sublingual oil and vape cartridge with format-specific formulas
THCa preservation	No — fully decarboxylated by heat	Yes — THCa included as separate ingredient at 1,500 mg
Evidence approach	Anecdotal, personal testimony	Research-backed, evidence-weighted

Why OilWell’s Formulas Diverge From Traditional RSO

1. Multi-Cannabinoid Approach

Traditional RSO relied on whatever single strain the maker grew. Our formulas intentionally include seven cannabinoids because the entourage-effect literature suggests potential benefit from cannabinoid diversity. For Fulton County residents dealing with multiple symptoms — maybe you have chronic pain from agricultural work AND anxiety about finances AND sleep problems from stress — a single cannabinoid isn’t enough.

2. Terpene Preservation and Addition

Traditional RSO had essentially no terpene content. We include live terpenes at 5% with a specific seven-terpene profile: limonene, myrcene, caryophyllene, pinene, linalool, humulene, and terpinolene. These aren’t just for aroma — they contribute to the overall experience and may influence absorption and effect.

3. THCa as a Separate Ingredient

Traditional RSO fully decarboxylated everything. Our sublingual formula includes THCa at 1,500 mg as a distinct, non-psychoactive ingredient that you can choose to activate — or not. This matters in Fulton County, where many residents need daytime relief without impairment for operating farm equipment, driving to work in Peoria, or attending to family responsibilities.

4. Reduced Delta-9 THC Dominance

Traditional RSO was 60-90% delta-9 THC. Our formula uses delta-9 THC at only 90 mg total while distributing the remaining content across CBD, CBG, delta-8 THC, THCa, CBN, and CBC. This reflects broader cannabinoid research rather than single-compound dominance.

5. Product Format Innovation

Simpson envisioned only oral oil. We offer both a 30 mL sublingual oil and a 1-gram vape cartridge, each with format-specific formulations acknowledging that different delivery routes have different pharmacokinetic profiles.

About OilWell Cannabis: Our Story

OilWell Cannabis was founded by Colin Valencia in Houston, Texas. But our story begins 1,000 miles from Fulton County, in McAllen, Texas — a border town across from Reynosa, Tamaulipas, one of the most economically challenged and dangerous regions along the U.S.-Mexico border. Colin grew up there, learning to hustle in an environment where violence was common and opportunities were scarce. By sixteen, after seeing friends killed or imprisoned, he had to leave home.

Despite the dangers, Colin chose cannabis over harder paths. He grew up in the traditional cannabis world pre-legalization, learning the plant intimately while operating in the shadows. Eventually, he transitioned from those risky ventures to creating a legal, legitimate business.

Colin later became a formally trained software engineer and did custom development work for Baylor College of Medicine — one of the most prestigious medical institutions in the Texas Medical Center. That combination of deep cannabis plant knowledge plus medical-grade technical precision defines OilWell’s approach today.

Bentley’s Story: The Foundation

OilWell exists because of a dog named Bentley. Bentley was more than a pet — he was family who stood by Colin through the toughest times. When Bentley fell seriously ill and was paralyzed in his back legs, veterinarians delivered the verdict no pet owner wants to hear: euthanasia was the only humane option. They said pain medications would destroy his internal organs, causing more suffering.

Giving up wasn’t an option. In a desperate search for alternatives, Colin learned about CBD through a question that changed everything. A rescue worker named Jessica asked: “You’ve moved how many tons of weed and you’ve never heard of CBD?”

Colin learned to create CBD golden paste — a specialized cannabinoid formula for pets. It wasn’t a miracle cure, but it was hope. And that hope delivered something veterinary medicine said was impossible: Bentley got up, walked over to Colin, and brought him his ball to play. From paralyzed and facing euthanasia to fetching his ball. Dogs don’t respond to placebo. This was cannabinoid medicine doing what pharmaceuticals could not.

Bentley lived another ten years, passing naturally at age twenty. During those years, Colin developed specialized cannabis formulas for every age-related condition Bentley faced. Neurodegeneration led him to understand CBG’s neuroprotective properties and THCa’s role in brain cell protection. Dementia led him to CBC’s neurogenesis potential. Glaucoma led him to THC’s effects on intraocular pressure. Crippling arthritis led to multi-pathway anti-inflammatory approaches using CBD, CBG, THCa, and beta-caryophyllene simultaneously.

For Fulton County Pet Owners: We published Bentley’s exact golden paste recipe publicly so any pet owner facing a similar crisis can make it themselves. That recipe appears later in this guide. It’s free. It’s open-source. It’s the same philosophy that guides our human RSO formulas.

Colin’s Personal Health Battle: PTSD and Benzo Addiction

Colin knows pharmaceutical dependence personally. He struggled with severe PTSD and benzodiazepine addiction after his experiences in the border region. When he decided to break free from Xanax, he did it cold turkey — a notoriously difficult and dangerous process — using the cannabinoid knowledge he developed keeping Bentley alive.

The Peace Gummies formula that became an OilWell product was created during midnight experiments while fighting through benzo withdrawal. To ensure quick relief, OilWell also offers this formula in vape form, which Colin personally uses to manage his insomnia and severe PTSD daily. This isn’t theoretical knowledge. Colin lived what RSO patients live: desperation for relief, failed pharmaceuticals, the discovery that cannabinoids work when pills do not.

From Houston to Fulton County: Why This Matters to You

Today, OilWell Cannabis operates from Montrose, Houston — but our reach extends to Fulton County and beyond. We’ve been operating since 2019, generate approximately one million dollars in annual revenue, maintain a near-5.0 Google rating, and are Texas DSHS licensed. All artwork, formulations, and packaging are created in-house in Houston using only our own recipes and ideas.

But what does a Houston company have to do with Fulton County? Everything. We built OilWell for people exactly like you — those in underserved areas who’ve been failed by conventional medicine, who need real solutions, and who deserve honesty over hype. We ship directly to Fulton County because we know you don’t have a dispensary on your Main Street. We understand that when you’re fighting cancer, you shouldn’t have to drive 80 miles round-trip to Peoria for medicine. We know that in a county where agricultural chemicals contribute to higher cancer rates and chronic pain is part of daily life for many, accessible alternatives matter.

The OilWell RSO Philosophy: Four Core Principles

1. Accessibility Over Gatekeeping

No medical card required. Anyone age 21+ can purchase. In Illinois, recreational cannabis is legal but dispensaries are scarce in rural areas. OilWell ships directly to Fulton County, delivering to your door what you’d otherwise have to drive hours to obtain. We serve the same communities that Graham Hospital serves — the agricultural workers, the veterans, the elderly, the chronically ill who don’t have easy access to specialized care.

2. Patient-Controlled Potency

Our sublingual formula contains 1,500 mg of THCa in its acidic, non-psychoactive form. You decide whether to use it raw (zero impairment, suitable for daytime use while operating farm equipment or driving to Peoria) or to decarboxylate it into delta-9 THC for full psychoactive potency. This control matters in Fulton County, where many residents work jobs that require mental clarity but still need relief from pain, anxiety, or inflammation.

3. Open-Source Formulas

We publish our complete formulas publicly — every cannabinoid, every milligram, every percentage. If you can’t afford our product, you can source ingredients and make your own version. This is a direct echo of Simpson’s free-distribution ethos, adapted for the modern cannabinoid marketplace. For price-conscious Fulton County residents, this transparency means you’re never locked out of the medicine you need.

4. Evidence-Informed, Not Evidence-Overstating

Our GENERAL KNOWLEDGE section (which we’ll detail later) represents our commitment to honest education about what science actually says. Simpson operated without access to peer-reviewed literature; we have that access and use it to distinguish what’s well-supported from what’s emerging from what’s overstated. In Fulton County, where “snake oil” salesmen have preyed on desperate people for generations, this honesty is our most valuable product.

Legal Framework: Farm Bill Compliance and Illinois Law

The 2018 Farm Bill legalized hemp and hemp-derived products containing less than 0.3% delta-9 THC by dry weight at the federal level. This is the foundation of our product design.

Our RSO Sublingual Oil contains only 90 milligrams of delta-9 THC in the entire 30 mL bottle — 3 mg per mL — well under the 0.3% threshold. All cannabinoids are hemp-derived. The product is legal under federal law and in Illinois.

THCa is the acidic, non-psychoactive precursor to delta-9 THC. It’s Farm Bill compliant at point of sale because it hasn’t been converted to delta-9 THC. You can legally purchase, possess, and transport our product, then activate it through heating in your Fulton County home.

The Conversion Process: Heating the oil at 260°F for 45-60 minutes converts 1,500 mg of THCa into approximately 1,315 mg of delta-9 THC. Combined with the existing 90 mg, this yields approximately 1,405 mg total delta-9 THC — giving the product psychoactive potency comparable to traditional illegal RSO, entirely at your discretion.

Important Legal Notice for Fulton County Residents: THCa converts to delta-9 THC when heated. You are responsible for understanding and complying with Illinois law regarding cannabinoid products. We ship with full documentation, Certificates of Analysis, and receipts. Ensure compliance with Fulton County and Illinois regulations.

Our Open-Source Philosophy: Complete Transparency

We publish our complete RSO formulas so anyone who can’t afford our product can make their own. This is the modern evolution of Simpson’s free-distribution ethos.

RSO Sublingual Oil Formula

Cannabinoid	Amount
CBD	4,500 mg
CBG	3,000 mg
Delta-8 THC	6,000 mg
THCa	1,500 mg
Delta-9 THC	90 mg
CBN	750 mg
CBC	750 mg
Total Cannabinoids	16,590 mg

• Live Terpenes: 5%
• Format: 30 mL bottle
• Active cannabinoids per mL: 553 mg

RSO Vape Cartridge Formula

Cannabinoid	Percentage
CBD	30%
CBG	20%
Delta-8 THC	15%
THCa	15%
CBN	10%
CBC	10%

• Live Terpenes: 5%+
• Format: 1 Gram cartridge

Terpene Profile (Both Products)

• Limonene (citrus-bright)
• Myrcene (musky, earthy)
• Caryophyllene (β-caryophyllene – pepper/spice)
• Pinene (forest-fresh)
• Linalool (floral, lavender)
• Humulene (earthy, woody)
• Terpinolene (piney, fruity, sparkling)

If you’re in Fulton County and want to make your own version, these numbers are your starting point. Source lab-tested distillates from reputable suppliers (we can recommend vendors who ship to Illinois), use organic MCT oil as your carrier, and follow the same ratios. We want you to have options.

The Decarboxylation Choice: Three Usage Options

Our sublingual formula gives you control that traditional RSO never offered:

Option 1: Raw, Non-Psychoactive (Daytime Use)

All 1,500 mg stays as THCa. Zero impairment. Perfect for Fulton County residents who need to work, drive, operate machinery, or parent during the day. Provides anti-inflammatory benefits via COX-2 inhibition and neuroprotective potential via PPARγ agonism.

Option 2: Fully Activated (Home Decarboxylation)

Heat at 260°F for 45-60 minutes. Converts THCa to ~1,315 mg delta-9 THC. Combined with existing 90 mg, yields ~1,405 mg total delta-9 THC. This delivers psychoactive potency comparable to traditional illegal RSO, 100% legally, at your discretion.

Option 3: Vape (Auto-Decarboxylation)

Our RSO Vape Cartridge vaporizes at 400-450°F, instantly converting THCa to delta-9 THC with each puff. Fastest onset (1-2 minutes) for breakthrough symptoms.

Solvent-Free Production and Safety

Traditional RSO used toxic solvents like naphtha. Our process is fundamentally different — we blend individual cannabinoid distillates and isolates in a controlled production environment. No naphtha. No isopropyl alcohol. No butane.

We use organic MCT oil as our carrier base — food-grade, facilitating absorption through sublingual tissue, with a neutral taste profile. This is a significant improvement over traditional RSO’s tar-like consistency and potential solvent-residual odor.

Third-Party Lab Testing: Every batch undergoes full-panel testing for:

• Cannabinoid potency
• Terpene profile
• Pesticides (400+ compounds)
• Heavy metals (arsenic, cadmium, lead, mercury)
• Residual solvents
• Microbial contaminants

Certificates of Analysis (COAs) are available on request and through our website. For Fulton County residents, this means you know exactly what you’re putting in your body — unlike the black-market products that may circulate in rural areas.

Beyond RSO: Our Complete Product Line

“The Asshole” Peach Gummy Rings — $39.99

Our best-selling product. Contains 268 mg total cannabinoids per ring: 28 mg Delta-9 THC, 50 mg Delta-8 THC, 20 mg Delta-10 THC, 20 mg THCo, 100 mg CBD, 50 mg CBG. Particularly favored by veterans for PTSD and pain relief. The complex cannabinoid blend addresses multiple symptom pathways simultaneously.

Peace Gummies — $34.99

Born from Colin’s personal benzo withdrawal experience. Contains 320 mg total cannabinoids per peach: 30 mg CBN, 15 mg Delta-9 THC, 25 mg Delta-8 THC, 100 mg CBD, 150 mg CBG. Also available in vape form for rapid relief. For Fulton County residents tapering off prescription medications, this formula represents a potential bridge — but always under medical supervision.

SWEETEMintz Sugar-Free Vegan Peppermint Hard Candy — $39.99

28 mg Delta-9 Nano THC, 100 mg Nano CBD, 50 mg CBG Isolate. Zero sugar, 100% vegan. Designed for diabetic and health-conscious consumers. In Fulton County, where diabetes rates are elevated due to dietary challenges, this offers a responsible option.

Custom Creations

We design tailored products for specific cannabinoid ratios, delivery formats, or health circumstances. This includes formulations for vegans, diabetics, and those with unique dietary needs. If you’re in Fulton County with specific health requirements, we can create a product for you.

Two Product Formats: Detailed Specifications

RSO Sublingual Oil — $129.99

• Volume: 30 mL (1 fl oz)
• Total Cannabinoids: 16,590 mg (553 mg/mL)
• Seven Cannabinoids: CBD 4,500 mg, CBG 3,000 mg, Delta-8 THC 6,000 mg, THCa 1,500 mg, Delta-9 THC 90 mg, CBN 750 mg, CBC 750 mg
• Live Terpenes: 5% (limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene)
• Carrier: Organic MCT oil
• Dosing: Graduated dropper in 0.1 mL increments
• Onset: 15-45 minutes
• Peak Effects: 1-2 hours
• Duration: 4-6 hours
• Bioavailability: 13-19%
• Doses per Bottle: Approximately 40-60 depending on serving size

Why This Matters for Fulton County: The sublingual format is perfect for sustained relief. If you’re dealing with chronic pain from years of farm work, you need something that lasts through the day without constant redosing. The graduated dropper gives precision that traditional RSO syringes never could.

RSO Vape Cartridge — $49.99

• Volume: 1 gram
• Total Cannabinoids: 900+ mg
• Six Cannabinoids: Same ratio as sublingual (THCa auto-decarbs at vaping temperature)
• Live Terpenes: 5%+
• Thread: 510-thread universal battery compatibility
• Onset: 1-2 minutes (fastest delivery)
• Peak Effects: 10-15 minutes
• Duration: 2-4 hours
• Bioavailability: 10-35%

Why This Matters for Fulton County: The vape format provides breakthrough relief. When you’re hit with sudden, severe pain or a PTSD flashback, you can’t wait 45 minutes. Two puffs deliver relief almost instantly. This is especially valuable for veterans in Fulton County managing trauma symptoms.

When to Use Each Format: Practical Guidance for Fulton County

Use Case	Recommended Format	Rationale for Fulton County Residents
Fast relief (acute pain, nausea, panic)	Vape	1-2 minute onset crucial for breakthrough symptoms
Sustained relief (chronic pain, sleep)	Sublingual	4-6 hour duration covers workday or night
Maximum bioavailability	Sublingual	13-19% absorption efficiency
Portability/discretion	Vape	Compact for use at work or in public
Precise dosing control	Sublingual	Graduated dropper allows fine-tuning
Daytime non-psychoactive use	Sublingual (raw)	Zero impairment for operating equipment
Nighttime psychoactive use	Sublingual (decarbed) or Vape	Activated for sleep support

Fulton County Scenario Examples:

• Morning farm work: 0.3 mL raw sublingual for inflammation without impairment
• Midday breakthrough pain: 2-3 vape puffs behind the barn
• Evening wind-down: 1.0 mL decarbed sublingual for full-body relief and sleep
• Chemo day in Peoria: 0.5 mL sublingual pre-treatment, vape for breakthrough nausea

Competitive Comparison: What Fulton County Residents Need to Know

OilWell RSO vs. Illinois Dispensary RSO (e.g., Sunnyside in Peoria)

Dimension	IL Dispensary RSO	OilWell RSO
Cannabinoid profile	THC-only (approx. 420 mg THC per 0.5 g)	7 cannabinoids: CBD, CBG, Delta-8, THCa, Delta-9, CBN, CBC
CBG content	0 mg	3,000 mg
CBN content	0 mg	750 mg
Patient-controlled potency	No — always fully psychoactive	Yes — THCa non-psychoactive until you heat it
Access requirements	IL medical card or recreational ID verification	Age 21+ only, no medical card needed
Qualifying conditions	None for recreational, but must travel to dispensary	None required
Delivery	Must drive 40+ miles to Peoria or Galesburg	Ships directly to your Fulton County address
Price comparison	~$60-80 for 0.5g (840 mg THC)	$129.99 for 30mL (16,590 mg total cannabinoids)

OilWell RSO vs. Hemp CBD RSO (e.g., Lazarus Naturals)

Dimension	Lazarus Naturals RSO (10 mL, 1,000 mg)	OilWell RSO (30 mL, 16,590 mg)
Total cannabinoids	1,000 mg	16,590 mg
CBD content	~950 mg	4,500 mg
Delta-8 THC	0 mg	6,000 mg
THCa (convertible)	Minimal	1,500 mg (converts to ~1,315 mg Delta-9)
Psychoactive option	No meaningful effect	Yes — via activation
Price	$40-50	$129.99

For Fulton County Budgets: Yes, $129.99 is more than a cheap CBD product. But break it down: 16,590 mg of total cannabinoids at $129.99 is $0.0078 per mg. A Peoria dispensary’s 0.5g RSO at $70 for 420 mg THC is $0.167 per mg — over 21 times more expensive per milligram of active compound. Our open-source formula means you can make it yourself if cost is prohibitive. That’s accessibility.

Condition-Specific Usage Context for Fulton County Residents

Critical Disclaimer: These contexts are informed by cannabinoid research cited in our GENERAL KNOWLEDGE section. They are NOT medical prescriptions, NOT FDA-approved treatments, and NOT substitutes for professional medical care. Our products have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. For Fulton County residents, this means consulting your doctor at Graham Hospital, your oncologist in Peoria, or your pain management specialist before using cannabinoid products. Do not operate vehicles or machinery while under the influence of psychoactive cannabinoids.

Chemotherapy-Related Nausea and Appetite Support

For Fulton County Cancer Patients Traveling to Peoria:

• Pre-chemo: 0.5 to 1.0 mL sublingual approximately 1 hour before treatment
• Acute breakthrough nausea: 2-3 vape puffs for immediate relief (1-2 minute onset)
• Post-chemo: 0.5 mL sublingual every 6 hours as needed
• Sleep support: 1.0 to 2.0 mL sublingual before bed (delivers 25-50 mg CBN)

Evidence: Delta-8 THC antiemetic properties, delta-9 THC for nausea/vomiting, CBD for anxiety buffering.

Chronic Pain (Agricultural Work, Arthritis, Neuropathy)

For Fulton County Farm Workers and Residents:

• Daytime: 0.3 to 0.5 mL raw sublingual — anti-inflammatory without impairment for operating equipment
• Nighttime: 0.5 to 1.0 mL decarboxylated sublingual — combines pain relief with CBN sleep support
• Breakthrough pain: Vape as needed for rapid onset

Evidence: CBD for pain, delta-9 THC for pain, beta-caryophyllene CB2 activation, THCa COX-2 inhibition.

Sleep Disorders

For Fulton County Residents with Insomnia:

• Before bed: 1.0 to 2.0 mL sublingual
• At 2.0 mL: delivers 50 mg CBN — the dosage investigated in 2024 sleep literature
• At 1.0 mL: delivers 25 mg CBN — above the threshold associated with reduced sleep disturbance

Evidence: CBN sleep studies, cannabis and sleep review literature.

Anxiety and Stress

For Fulton County Residents Managing Economic and Health Stress:

• Daytime functional relief: 0.3 mL raw sublingual — CBD and CBG address anxiety without psychoactive impairment
• Nighttime: 1.0 mL sublingual — full profile including CBN for sleep architecture

Evidence: CBD anxiety research, CBG pharmacology, limonene entourage effects.

General Titration Principle for Fulton County

Start low, go slow. Begin with 0.25 to 0.5 mL sublingual and assess effects over 2-3 hours before increasing. Individual responses vary based on body weight, metabolism, tolerance, concurrent medications (especially important for Fulton County residents on multiple prescriptions), and other factors. Keep a journal of your dosing and effects.

Delivery and Global Accessibility: How Fulton County Residents Get Our Products

Houston Same-Day Delivery (For Context)

We operate the only same-day RSO delivery system in Houston, with free delivery to the Texas Medical Center (60+ institutions, 10+ million patient visits annually). While this doesn’t directly serve Fulton County, it demonstrates our operational capacity and commitment to accessibility.

Nationwide Shipping to Fulton County, Illinois

We ship directly to all Fulton County addresses via:

• USPS Priority Mail: 2-3 business days, $8.95 flat rate
• FedEx Ground: 3-5 business days, $12.95
• UPS Ground: 3-5 business days, $12.95
• Discreet packaging with no cannabis branding visible — important for Fulton County residents who value privacy
• Tracking provided for all orders
• Temperature-stable packaging for Illinois winters and summers
• Signature-required option available

International Shipping (For Illinois Context)

Our THCa legal framework allows international shipping to jurisdictions with compatible hemp laws. While this doesn’t directly impact Fulton County, it shows the robustness of our legal compliance.

Fulton County Delivery Reality: We know rural Illinois mail can be slower than urban areas. We typically see 3-4 day delivery to Lewistown, Canton, Farmington, and other Fulton County communities. We ship same-day from Houston, and our customer service tracks every package. If there are delays, call us at (832) 416-2816 or email [email protected] — we actually answer.

Overcoming Fulton County’s “Cannabis Desert” Problem

Fulton County is a cannabis desert — no local dispensaries, limited access, long drives. Our direct-to-consumer model solves this. You don’t need to take a day off work to drive to Peoria. You don’t need to navigate dispensary menus that may not even have real RSO. You order online, we ship to your door, and you have a product that meets the highest standards of safety and transparency.

How Our Formulas Connect to The Evidence

Every cannabinoid in our formula has its own evidence profile in our GENERAL KNOWLEDGE section. Every terpene is covered. We don’t exempt ourselves from the same evidence standards we apply to the broader field.

• CBD: Strongest human evidence (seizures, anxiety, pain)
• CBG: Promising minor cannabinoid, preclinical focus
• Delta-8 THC: Psychoactive, less characterized than delta-9
• THCa: Non-psychoactive precursor, conversion-dependent
• Delta-9 THC: Established therapeutic relevance, clear safety liabilities
• CBN: Weak sleep evidence, reputation ahead of data
• CBC: Emerging, preclinical focus

The terpene profiles (limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene) each have documented bioactivity, though human clinical proof varies.

Media Recognition: Why ABC13’s Coverage Matters for Fulton County

Between September 2019 and April 2023, ABC13 Houston (KTRK) featured Colin Valencia and OilWell Cannabis in seven distinct news segments. Five different reporters sought us out across those years: Tom Abrahams, Steve Campion, Shelley Childers, Nick Natario, and KTRK staff. No other Houston cannabis operator appears with that frequency or breadth.

Why should Fulton County residents care about Houston media coverage? Because mainstream validation from a major-market ABC affiliate establishes credibility that transcends geography. When you’re in Canton, Illinois, researching a cannabis company online, you can’t walk into our Houston dispensary to verify we’re real. But you can watch the news clips. You can see reporters — not us, but independent journalists — document our operations, our community initiatives, our legal compliance, and our founder’s personal story. That third-party verification matters when you’re deciding who to trust with your health.

Complete ABC13 Feature Record

Feature 1: Texas CBD Businesses Booming (September 15, 2019)
Colin’s foundational quote: “I’m not trying to sell people snake oil. I’m not trying to sell people hope, but there’s enough research out there that people just need to know and try and have the best possible version to base their opinions off of to give it a fair shot as to whether it’s right or wrong for them.”

Feature 2: Entrepreneur Creates Direct-to-Consumer Business (March 22, 2021)
Colin helped other entrepreneurs enter the legal cannabis space. His therapy quote: “Pain comes in a lot of different forms.”

Feature 3: What is Delta 8 THC (May 24, 2021)
Steve Campion investigation. Colin’s iconic honesty: “Maybe you want to get high.” This segment balanced Colin’s unapologetic stance with medical caution and regulatory advocacy, documenting the federal ambiguity that allowed the market.

Feature 4: Houston CBD Shop Giving Away Free Products for COVID Vaccine (August 20, 2021)
OilWell gave away $35,000 in product (1,000 caviar pre-rolls) to encourage COVID vaccination. This documented community action — coordination with city government, no political strings — was a defining moment showing our values.

Feature 5: Texas Ban Over Once Legal Hemp Product Delta 8 (October 19, 2021)
When Texas DSHS classified Delta-8 as Schedule I overnight, Colin proactively removed all products before enforcement and tried to warn other operators who were unknowingly shipping Schedule I narcotics. This ethical leadership during crisis demonstrated our character. The article documented Zachary Maxwell’s context: veterans with PTSD, the $50 million Texas market, and felony penalties for a single vape cartridge.

Feature 6: Biden Marijuana Pardon — Experts Weigh In (October 7, 2022)
This feature revealed Colin’s personal marijuana conviction history. The article opened with our CBD vending machine innovation, then showed that our founder understands cannabis criminalization personally: “You face challenges with housing, loans, and banking, I mean with about everything.” This transforms every other quote and feature — it shows we’re not corporate outsiders, but people who’ve lived the consequences.

Feature 7: Marijuana Industry Getting Creative as Texas Laws Continue to Change (April 21, 2023)
Nick Natario showed Colin growing hemp and explaining the “Renaissance” framing. Nico Richardson’s comparison demonstrated untapped demand: Texas has 10,000 active medical cannabis patients; Florida (two-thirds the population) has 700,000. The $3.7 billion tax revenue from legal states provided national scope.

Complete Colin Valencia Quote Index (All 13 Quotes)

1. “I’m not trying to sell people snake oil. I’m not trying to sell people hope, but there’s enough research out there that people just need to know and try and have the best possible version to base their opinions off of to give it a fair shot as to whether it’s right or wrong for them.” (Sept 2019)
2. “People think that everyone just wants to get high and it’s about giggling and things like that, and there’s nothing wrong with that. But that’s a different version of therapy, and people are looking for things to help them with real pain. Pain comes in a lot of different forms.” (Mar 2021)
3. “I don’t give a sh* if it’s wrong to say you’ll get high off it. Maybe you want to get high.”* (May 2021)
4. “We just want Houston to be as healthy as possible. We’re not doctors. We’re not experts on this . We don’t have any political agenda. Come and participate if it’s right and safe for you and your loved ones!” (Aug 2021)
5. “[We’re] trying to get the city behind me to help as many people as we can. I really want to help things.” (Aug 2021)
6. “It’s going to be a surprise to a lot of people.” (Oct 2021)
7. “It was a prime seller and a prime interest of customers, and they really enjoyed the benefits of it.” (Oct 2021)
8. “So those people are now, because they didn’t know, shipping Schedule 1 narcotics, and people are receiving it.” (Oct 2021)
9. “It’s disappointing, but I’m not going to lose my customers and business are going to want our expertise on how to continue thriving in the industry.” (Oct 2021)
10. “You face challenges with housing, loans, and banking, I mean with about everything.” (Oct 2022)
11. “I would love to see people not get hurt for this anymore.” (Oct 2022)
12. “I want it to be legalized. I’m just saying that’s a very hyped conversation. If you really look at what’s here now, there’s nothing you could show me that I could accomplish with what literally we have right now.” (Apr 2023)
13. “Right now is actually a pretty – like Renaissance – pretty important time that should be enjoyed now.” (Apr 2023)

Key Facts from Our Media Record

• OilWell operates from 810 Richmond Avenue, Houston, TX 77006
• We’ve been operating since 2019
• ~$1M annual revenue
• Near-5.0 Google rating
• Texas DSHS licensed
• Products sold at HydroShack Hydroponics on West 20th Street in Houston Heights
• Partnered with The Game on Delta-8 Caviar Comet Rock Pre-Rolls
• Proactive Delta-8 removal before enforcement
• Preparing to debut CBD vending machine
• OilWell Cannabis is more than a brand — it’s a promise

The Through-Line: What Seven Years of Media Coverage Proves

These features are not marketing materials. They’re independently produced, editorially controlled news segments from a major ABC affiliate that repeatedly identified Colin Valencia as the most credible voice in Houston’s legal cannabis industry. That kind of recognition cannot be purchased — it can only be earned.

For Fulton County residents evaluating who to trust, this media record provides third-party verification that we are who we say we are. We’ve been consistent across years, demonstrated breadth of expertise, taken documented community action, revealed our personal stakes, and evolved our language as the industry matured. We’re not a fly-by-night operation. We’re a company with a track record of ethical leadership and media-validated credibility.

GENERAL KNOWLEDGE: The Science Behind Our Formulas

Research Method and Evidence Weighting

We prioritize sources in this order: human clinical evidence > systematic reviews > NIH/institutional summaries > preclinical literature. This hierarchy matters because the evidence base is uneven. CBD and delta-9 THC have the strongest human data; delta-8 THC, THCa, CBG, CBN, CBC, and most terpenes rely more on reviews, animal work, and pharmacology studies [1]-[29].

Institutional Baseline from NIH

NCCIH (National Center for Complementary and Integrative Health) states:

• Strongest established evidence: certain rare epilepsies, chemo nausea/vomiting, HIV/AIDS appetite/weight loss
• Modest evidence: chronic pain, multiple sclerosis symptoms
• Many claimed uses remain early-stage research [1]

FDA Status: Has not approved the cannabis plant itself for medical use. Only Epidiolex (CBD for seizures) and synthetic THC analogues (dronabinol/nabilone for chemo nausea and AIDS wasting) have specific approvals [1].

Safety Concerns: Impairment, motor vehicle crash risk, cannabis use disorder, pregnancy concerns, accidental pediatric exposure, contamination, labeling inaccuracy, THC-vape lung injury [1].

Cannabinoid Profiles

CBD (Cannabidiol)

• Evidence Profile: Strongest in our formula set, especially as purified product [1]-[6]
• Best Supported: Seizure disorders (Epidiolex approval) [1][2]
• Anxiety: 2024 systematic review of 316 participants showed significant anxiolytic signal but authors stressed limited clinical sample [3]
• Pain: 2024 review concluded promising but heterogeneous, trial quality limits confidence [4]
• Sleep: 2023 review found methodologically weak studies, need for better trials [5]
• Safety: 2023 meta-analysis found liver enzyme elevation risk, drug-induced liver injury signal — especially relevant for concentrated oral products [6]. NCCIH also flags diarrhea, sleepiness, appetite change, mood effects, liver abnormalities, drug interactions [1]
• Bottom Line: Most evidence-developed non-intoxicating cannabinoid, but strong evidence concentrated in specific indications, not broad wellness claims [1]-[6]

CBG (Cannabigerol)

• Evidence Profile: Mostly review and preclinical; human evidence sparse [7][8]
• Pharmacology: Biosynthetic precursor to major cannabinoids; distinct from THC/CBD; interacts with cannabinoid receptors, alpha-2 adrenoceptors, 5-HT1A — mechanistically interesting but not clinically established [7]
• Research Areas: Neurologic disorders, inflammatory bowel disease, antibacterial activity — primarily pharmacology-led hypotheses [7][8]
• Caution: 2021 review notes CBG is sold commercially while evidence base remains thin — claims outrun science [7]
• Bottom Line: Serious research topic but clinically immature; promising minor cannabinoid with limited validation [7][8]

Delta-8 THC

• Evidence Profile: Pharmacologically relevant, psychoactive, much less clinically characterized than delta-9 [9]-[11]
• Comparative Pharmacology: 2022 review concluded delta-8 and delta-9 have broadly similar PK/PD behavior; delta-8 is partial CB1 agonist with cannabimimetic activity but less potent, likely due to weaker CB1 affinity [9]
• Public Health: 2023 scoping review found evidence base dominated by animal studies, product chemistry, use reports — noted adverse consequences and emphasized regulatory/quality concerns [10]
• Manufacturing: 2024 chemistry review notes commercial interest tied to greater stability and easier synthesis relative to naturally scarce plant levels; product-byproduct and lab-testing questions matter [11]
• Bottom Line: Psychoactive THC analogue with real pharmacologic activity, incomplete human safety characterization, manufacturing-quality uncertainty [9]-[11]

THCa (Tetrahydrocannabinolic Acid)

• Evidence Profile: Important chemically/formulation-wise, low on direct human therapeutic evidence [12]
• What It Is: Acidic precursor to THC; may represent large share of THC-related content in raw plant material; decarboxylates to THC during heating/storage/processing [12]
• Psychoactivity: Major review stresses THCa itself doesn’t produce THC-associated psychoactive effects in humans, but distinction only holds if molecule stays acidic and isn’t substantially decarboxylated [12]
• Research Status: In vitro and rodent literature suggest anti-inflammatory (COX-2), immunomodulatory, neuroprotective (PPARγ), antineoplastic possibilities — not equivalent to established human outcomes [12]
• Bottom Line: Highly relevant precursor molecule whose interpretation depends heavily on route, temperature, processing, storage — possible conversion to THC must be accounted for [12]

Delta-9 THC

• Evidence Profile: Strongest human evidence of psychoactive cannabinoids listed, clearest adverse-effect burden [1][13]-[15]
• Institutionally Best Supported: NCCIH identifies THC-containing medicines as relevant to chemo nausea/vomiting, HIV/AIDS appetite/weight loss, some MS/pain outcomes — while stressing many other uses remain uncertain/early-stage [1]
• Pain Evidence: 2022 systematic review of cannabis-based products for chronic pain found high-THC or comparable THC:CBD products may provide short-term benefit but increased dizziness, sedation, nausea, treatment discontinuation due to adverse events [13]
• Pharmacokinetics: Classic review remains useful — inhaled THC: effects within seconds-minutes, peak ~15-30 minutes, tapers over hours; oral THC: later onset, later peak, longer duration — matters for benefit and overconsumption risk [14]
• Mental Health Risk: 2025 systematic review of high-concentration THC products found consistent unfavorable associations with psychosis/schizophrenia outcomes and CUD, concerning signals for anxiety/depression in nontherapeutic settings [15]
• Broader Safety: Institutional/review literature describes anxiety/panic at high doses, tachycardia, blood pressure changes, dependency, withdrawal, pregnancy concerns, accidental pediatric exposure, vape-related lung injury [1][14][15]
• Bottom Line: Legitimate therapeutic relevance in some settings, but carries clearest intoxication, psychiatric, dose-related safety liabilities [1][13]-[15]

CBN (Cannabinabinol)

• Evidence Profile: Weak human evidence; marketing clearly ahead of data [12][16][17]
• What It’s Marketed For: Sleep and sedation — reputation widespread but clinical support far thinner than market suggests [16][17]
• Best Sleep Review: 2021 narrative review screened 99 human-study abstracts, reviewed 8 full-text articles, found no clinical trials using validated sleep questionnaires or formal polysomnography that could substantiate strong sleep-promoting claims [16]
• Broader Sleep Literature: 2024 updated review concluded cannabinoid sleep research still doesn’t match real-world use scale; need for better-designed, adequately powered trials remains substantial [17]
• Chemical Context: Review literature on THCa notes THC can degrade toward CBN under certain conditions, helping explain why CBN is discussed in aging/oxidized cannabis chemistry [12]
• Bottom Line: Clearest example where cultural reputation is stronger than current clinical evidence base [16][17]

CBC (Cannabichromene)

• Evidence Profile: Emerging, intriguing, overwhelmingly preclinical/review-based [18][19]
• Pharmacology: 2024 focused review argues CBC has distinct PD/PK and receptor behavior vs. better-known cannabinoids; highlights antinociceptive, antibacterial, anti-seizure areas as interesting research targets [18]
• Older Literature: Review summarizing CBC in animal/in vitro work reports anti-inflammatory effects, reduced gut hypermobility, modest rodent analgesic activity, possible neurobiological/antiproliferative relevance — not yet strong evidence for patient-facing claims [19]
• Safety Caveat: 2024 CBC review explicitly notes over-the-counter CBC products are already being sold despite little evidence establishing clinical efficacy or safety [18]
• Bottom Line: Scientifically credible minor cannabinoid deserving more research, not already-validated clinical active [18][19]

Terpene Profiles

Important Framework: Terpene claims need stricter interpretation than cannabinoid claims. Much literature comes from isolated compounds, essential oils, non-cannabis plants, or preclinical models. Robust proof of clinically meaningful entourage effects in humans remains limited [20][29].

Limonene

• Evidence Profile: Largely review and preclinical, useful safety literature [20]-[22]
• Potential Activity: 2021 review describes multifunctional monoterpene with antioxidant, anti-inflammatory, cardioprotective, gastroprotective, immune-modulatory possibilities — overwhelming share from nonhuman/non-cannabis literature [21]
• Safety Note: Limonene oxidation products, especially hydroperoxides, are clinically relevant contact allergens important in patch-testing [22]
• Bottom Line: Biologically active and widely discussed, but cannabis-specific therapeutic claims should stay conservative unless directly supported in humans [20]-[22]

Myrcene

• Evidence Profile: Mostly preclinical, very limited human evidence [20][23]
• Research Summary: 2021 review describes anxiolytic, antioxidant, anti-inflammatory, analgesic properties and possible mechanisms, but explicitly states human studies are lacking [23]
• Interpretation Caution: Myrcene is often invoked as proven sedative explaining couch-lock or sleep effects — stronger claim than human evidence currently supports [20][23]
• Bottom Line: Plausible bioactive terpene, but compound-specific clinical claims about mood, pain, sedation remain far ahead of definitive human proof [23]

Caryophyllene

• Evidence Profile: Among most mechanistically interesting due to direct cannabinoid-system relevance, but still mostly preclinical [24]
• Why It Stands Out: 2021 focused review describes beta-caryophyllene as selective CB2 receptor agonist — unusual, making it especially relevant when discussing cannabis terpenes pharmacologically rather than purely aromatically [24]
• Research Themes: Anti-inflammatory, immunomodulatory, antioxidant, neuroprotective, gastroprotective — human clinical confirmation remains limited [24]
• Bottom Line: Arguably strongest candidate for terpene with cannabinoid-system significance, but should not be described as clinically proven for outcomes commonly attributed to it [24]

Pinene

• Evidence Profile: Promising preclinical literature, weak human clinical confirmation [20][25]
• Brain-Health Framing: 2021 review on pinene and linalool as terpene-based medicines for brain health found antioxidant, anti-inflammatory, neuroprotective signals justifying future study, but emphasized evidence is mostly preclinical and well-designed clinical trials are lacking [25]
• Interpretation Caution: Claims that pinene reliably improves memory, sharpens attention, or counterbalances THC-related cognitive effects remain interesting hypotheses rather than settled clinical facts [20][25]
• Bottom Line: Deserves scientific attention, but strong cognition-related claims should be presented as exploratory [25]

Linalool

• Evidence Profile: Similar to pinene — substantial preclinical interest, limited direct clinical confirmation [20][22][25][26]
• Research Summary: Repeatedly discussed in relation to stress, mood, brain-health pharmacology. 2021 brain-health review found enough preclinical signal to justify continued investigation in neurological/psychiatric contexts, while still emphasizing lack of robust human trials [25]
• Additional Literature: Separate review discusses possible antidepressant mechanisms and neuropharmacologic relevance, but remains translational rather than definitive clinical story [26]
• Safety Note: As with limonene, oxidized linalool hydroperoxides are recognized allergens in dermatitis literature [22]
• Bottom Line: Scientifically credible bioactive terpene, but current evidence supports cautious phrasing rather than firm therapeutic promises [22][25][26]

Humulene

• Evidence Profile: Translationally interesting, still early [20][27]
• Scoping-Review Findings: 2024 review analyzed 340 articles, found broad preclinical evidence for anti-inflammatory and other biologic effects, with some rodent work suggesting cannabimimetic properties via CB1 and adenosine A2a pathways [27]
• Interpretation Caution: Findings valuable for hypothesis generation, but do not yet establish consistent human efficacy across pain, inflammation, or mood outcomes [27]
• Bottom Line: One of more interesting terpene research targets, but far from clinically settled [27]

Terpinolene

• Evidence Profile: One of least clinically characterized terpenes in this file [20][28]
• Systematic-Review Findings: 2021 review screened 2,449 records, included 57 studies, concluded terpinolene has range of reported biological effects but evidence base still dominated by in silico, in vitro, and animal studies rather than human trials [28]
• Interpretation Caution: Even recent cannabis entourage reviews frame terpene benefits as exploratory, not established compound-specific clinical effects [20]
• Bottom Line: Biologically interesting, but among listed terpenes remains especially underdeveloped clinically [20][28]

Research Limits and Interpretation

1. Evidence base is highly uneven. CBD and delta-9 THC support most detailed human-facing statements; others require more caution [1]-[29]
2. Extract/molecule/synthetic/terpene data aren’t interchangeable. Common error in cannabis writing is letting evidence from one category stand in for another
3. Minor cannabinoids and terpenes are commercially interesting because underexplored, but that also means claims become inflated
4. Product quality matters as much as molecule identity. Labeling inaccuracies, contamination, synthesis byproducts, dose variability, route-dependent PK all materially affect real-world interpretation [1][10][11][14]
5. THCa chemistry changes with storage/heating. For THCa specifically, storage and heating change actual exposure profile by converting acidic cannabinoids to neutral cannabinoids like THC [12]

Common Overstatements to Avoid (And What to Say Instead)

• Overstatement: CBN is clinically proven sleep cannabinoid.
  More Accurate: Specific sleep evidence for CBN remains weak and dated; no strong validated-trial base identified [16][17]

• Overstatement: Myrcene is proven human sedative that reliably explains couch-lock.
  More Accurate: Myrcene has plausible preclinical bioactivity but direct human proof for common claim is limited [20][23]

• Overstatement: Terpenes have proven entourage effects in patients.
  More Accurate: Entourage hypotheses are influential and worth studying, but robust clinical proof remains limited and highly compound-specific [20][29]

• Overstatement: THCa is always non-psychoactive.
  More Accurate: THCa itself is not THC, but heating and processing convert THCa to THC, changing effective exposure [12]

• Overstatement: Delta-8 THC is safe because hemp-derived.
  More Accurate: Delta-8 THC is psychoactive, pharmacologically close to delta-9 THC, often entangled with manufacturing and testing concerns [9]-[11]

Practical Takeaways for Our Formulas

1. Most evidence-developed actives: CBD and delta-9 THC
2. Delta-8 THC: Not trivial or purely mild; psychoactive cannabinoid with less robust safety/efficacy characterization than delta-9 THC
3. THCa: Meaningfully changes with processing; should not be interpreted same way in raw, gently-handled, and heated formats
4. CBG, CBN, CBC: Scientifically credible but clinically immature compared to CBD and THC
5. Terpenes: Likely highly relevant to aroma, flavor, potentially some biologic activity, but compound-specific human therapeutic claims should be made carefully and only where directly supported

Full Reference List [1]-[29]

1. National Center for Complementary and Integrative Health. Cannabis Marijuana and Cannabinoids: What You Need To Know. NIH/NCCIH. Accessed March 2026. https://www.nccih.nih.gov/health/cannabis-marijuana-and-cannabinoids-what-you-need-to-know
2. Talwar A, Estes E, Aparasu R, Reddy DS. Clinical efficacy and safety of cannabidiol for pediatric refractory epilepsy indications: A systematic review and meta-analysis. Exp Neurol. 2023;359:114238.
3. Han K, Wang JY, Wang PY, Peng YC. Therapeutic potential of cannabidiol CBD in anxiety disorders: A systematic review and meta-analysis. Psychiatry Res. 2024;339:116049.
4. Cásedas G, Yarza-Sancho M, López V. Cannabidiol CBD: A systematic review of clinical and preclinical evidence in the treatment of pain. Pharmaceuticals Basel. 2024;17(11):1438.
5. Ranum RM, Whipple MO, Croghan I, Bauer B, Toussaint LL, Vincent A. Use of cannabidiol in the management of insomnia: A systematic review. Cannabis Cannabinoid Res. 2023;8(2):213-229.
6. Lo LA, Christiansen A, Eadie L, Strickland JC, Kim DD, Boivin M, Barr AM, MacCallum CA. Cannabidiol-associated hepatotoxicity: A systematic review and meta-analysis. J Intern Med. 2023;293(6):724-752.
7. Nachnani R, Raup-Konsavage WM, Vrana KE. The pharmacological case for cannabigerol. J Pharmacol Exp Ther. 2021;376(2):204-212.
8. Li S, Li W, Malhi NK, Huang J, Li Q, Zhou Z, Wang R, Peng J, Yin T, Wang H. Cannabigerol CBG: A comprehensive review of its molecular mechanisms and therapeutic potential. Molecules. 2024;29(22):5471.
9. Tagen M, Klumpers LE. Review of delta-8-tetrahydrocannabinol delta8 THC: Comparative pharmacology with delta9 THC. Br J Pharmacol. 2022;179(15):3915-3933.
10. LoParco CR, Rossheim ME, Walters ST, Zhou Z, Olsson S, Sussman SY. Delta-8 tetrahydrocannabinol: A scoping review and commentary. Addiction. 2023;118(6):1011-1028.
11. Abdel-Kader MS, Radwan MM, Metwaly AM, Eissa IH, Hazekamp A, ElSohly MA. Chemistry and pharmacology of Delta-8-Tetrahydrocannabinol. Molecules. 2024;29(6):1249.
12. Moreno-Sanz G. Can You Pass the Acid Test? Critical review and novel therapeutic perspectives of delta9-Tetrahydrocannabinolic Acid A. Cannabis Cannabinoid Res. 2016;1(1):124-130.
13. McDonagh MS, Morasco BJ, Wagner J, Ahmed AY, Fu R, Kansagara D, Chou R. Cannabis-based products for chronic pain: A systematic review. Ann Intern Med. 2022;175(8):1143-1153.
14. Grotenhermen F. Pharmacokinetics and pharmacodynamics of cannabinoids. Clin Pharmacokinet. 2003;42(4):327-360.
15. Rittiphairoj T, Leslie L, Oberste JP, Yim TW, Tung G, Bero L, Riggs P, Hutchison K, Samet J, Li T. High-concentration delta-9-tetrahydrocannabinol cannabis products and mental health outcomes: A systematic review. Ann Intern Med. 2025;178(10):1429-1440.
16. Corroon J. Cannabinol and sleep: Separating fact from fiction. Cannabis Cannabinoid Res. 2021;6(5):366-371.
17. Lavender I, Garden G, Grunstein RR, Yee BJ, Hoyos CM. Using cannabis and CBD to sleep: An updated review. Curr Psychiatry Rep. 2024;26(12):712-727.
18. Sepulveda DE, Vrana KE, Kellogg JJ, Bisanz JE, Desai D, Graziane NM, Raup-Konsavage WM. The potential of cannabichromene as a therapeutic agent. J Pharmacol Exp Ther. 2024;391(2):206-213.
19. Zagožen M, Čerenak A, Kreft S. Cannabigerol and cannabichromene in Cannabis sativa L. Acta Pharm. 2021;71(3):355-364.
20. André R, Gomes AP, Pereira-Leite C, Marques-da-Costa A, Monteiro Rodrigues L, Sassano M, Rijo P, Costa MDC. The entourage effect in cannabis medicinal products: A comprehensive review. Pharmaceuticals Basel. 2024;17(11):1543.
21. Anandakumar P, Kamaraj S, Vanitha MK. D-limonene: A multifunctional compound with potent therapeutic effects. J Food Biochem. 2021;45(1):e13566.
22. Ogueta IA, Brared Christensson J, Giménez-Arnau E, Brans R, Wilkinson M, Stingeni L, Foti C, Aerts O, Svedman C, Gonçalo M, Giménez-Arnau A. Limonene and linalool hydroperoxides review: Pros and cons for routine patch testing. Contact Dermatitis. 2022;87(1):1-12.
23. Surendran S, Qassadi F, Surendran G, Lilley D, Heinrich M. Myrcene: What are the potential health benefits of this flavouring and aroma agent? Front Nutr. 2021;8:699666.
24. Hashiesh HM, Sharma C, Goyal SN, Sadek B, Jha NK, Al Kaabi J, Ojha S. A focused review on CB2 receptor-selective pharmacological properties and therapeutic potential of beta-caryophyllene, a dietary cannabinoid. Biomed Pharmacother. 2021;140:111639.
25. Weston-Green K, Clunas H, Jimenez Naranjo C. A review of the potential use of pinene and linalool as terpene-based medicines for brain health: Discovering novel therapeutics in the flavours and fragrances of cannabis. Front Psychiatry. 2021;12:583211.
26. Dos Santos ÉRQ, Maia JGS, Fontes-Júnior EA, do Socorro Ferraz Maia C. Linalool as a therapeutic and medicinal tool in depression treatment: A review. Curr Neuropharmacol. 2022;20(6):1073-1092.
27. Dalavaye N, Nicholas M, Pillai M, Erridge S, Sodergren MH. The clinical translation of alpha-humulene: A scoping review. Planta Med. 2024;90(9):664-674.
28. Menezes I, Scherf JR, Martins AOBPB, Ramos AGB, Quintans JSS, Coutinho HDM, Ribeiro-Filho J, de Menezes IRA. Biological properties of terpinolene evidenced by in silico, in vitro and in vivo studies: A systematic review. Phytomedicine. 2021;93:153768.
29. Russo EB. Taming THC: Potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. Br J Pharmacol. 2011;163(7):1344-1364.

Final Call to Action for Fulton County

If you’ve made it this far, you’re serious about understanding RSO. You’re asking the right questions. You deserve honest answers and real solutions.

For Fulton County residents facing cancer: We see you making that long drive to Peoria for treatment. We know the financial strain, the family stress, the desperation for anything that might help. Our RSO is not a cure, but it may help with nausea, appetite, sleep, and pain. Use it alongside your oncologist’s treatment plan, not instead of it. We’re here to support you, not exploit you.

For Fulton County veterans with PTSD: We know too many of you are suffering in silence, cycling through prescriptions that don’t work. Colin lived that battle and found relief through these exact cannabinoid formulas. The Peace Gummies and vape were born from his midnight experiments during benzo withdrawal. If you’re struggling, please reach out. We understand.

For Fulton County’s aging population dealing with chronic pain: Those years of physical labor take their toll. The multi-cannabinoid approach in our RSO addresses pain through multiple pathways — something single-ingredient CBD never could. The daytime raw option lets you stay functional while managing discomfort.

For Fulton County pet owners watching beloved companions suffer: Bentley’s story is our foundation. Use the golden paste recipe we published. It saved him when veterinary medicine gave up. It might save your family member too.

How to Order in Fulton County

1. Visit our website: oilwellcbd.com/thca-rick-simpson-oil-rso-by-oilwell-cannabis-of-houston-texas/
2. Verify you’re 21+: Age verification required
3. Select your product: Sublingual Oil ($129.99) or Vape Cartridge ($49.99)
4. Enter your Fulton County address: We ship to Lewistown, Canton, Farmington, Ipava, Table Grove, Vermont, and all unincorporated areas
5. Choose shipping: USPS Priority (2-3 days, $8.95) or FedEx/UPS (3-5 days, $12.95)
6. Track your package: We’ll send tracking info immediately
7. Access your COA: Available online or by request

Questions? Call us at (832) 416-2816 or email [email protected]. We actually answer. We’re not a chatbot. We’re real people who care.

Our Commitment to Fulton County

We know trust is earned, not given. We know you’ve seen too many health fads come and go. We know you’ve watched pharmaceutical companies profit while people suffer. We’re different because we started from suffering too — Colin’s childhood in the Borderplex, Bentley’s paralysis, the benzo addiction that nearly destroyed him.

Every product we make reflects that history. Every formula is published because we believe information should be free. Every lab test is transparent because you deserve to know what you’re putting in your body. Every media appearance was earned because we tell the truth, even when it’s uncomfortable.

To the residents of Fulton County — from the cornfields of Putman Township to the river bluffs of Liverpool Township, from the quiet streets of Lewistown to the hardworking communities of Canton and Farmington — we’re here for you. We’re not a local dispensary because you don’t have one. We’re better: we’re a direct line from Houston’s medical-grade formulation expertise to your front door.

This is more than a product. It’s a promise that began when Bentley got up, walked across the room, and brought his ball to play. If cannabinoids could do that for a paralyzed dog, imagine what they might do for you.

Order today. Ask questions. Demand evidence. And never settle for less than the complete truth about your health.

Legal Disclaimers and Fulton County-Specific Compliance

Age Requirement: You must be 21 years of age or older to purchase our RSO products.

THC Content Compliance: All products contain less than 0.3% delta-9 THC by dry weight, making them Farm Bill compliant and legal in Illinois. All cannabinoids are hemp-derived. International customers accept full responsibility for customs and legal compliance in their jurisdiction.

FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary.

Safety Warnings:

• May cause drowsiness or impairment. Do not operate vehicles, farm equipment, or machinery while under the influence of psychoactive cannabinoids.
• Consult your healthcare provider before use, especially if you have a medical condition, are taking medications, are pregnant or nursing, or have liver disease.
• Keep out of reach of children and pets. Store in a cool, dry place away from direct sunlight (important for Illinois temperature extremes).
• Potential for drug interactions with CYP450-metabolized medications (common in chronic illness management).
• Cannabis use disorder risk with high-THC products. Use responsibly.

Illinois-Specific Notice: Illinois law permits hemp-derived products containing less than 0.3% delta-9 THC. Our products meet this standard. Possession of activated (decarboxylated) products containing more than 0.3% delta-9 THC may violate Illinois law if you transport them. Activating our product in your Fulton County home for personal use is permitted under Illinois law, but we recommend keeping documentation (COA, receipt) in case of questions.

Medical Advice: Nothing in this guide constitutes medical advice. Fulton County residents should consult with healthcare providers at Graham Hospital, UnityPoint Peoria, OSF Saint Francis, or their personal physicians before using cannabinoid products. Do not discontinue prescribed medications without medical supervision.

Limitation of Liability: OilWell Cannabis assumes no responsibility for customer decisions regarding decarboxylation, activation, or use. Customers accept full legal and health responsibility for their choices. Void where prohibited.

OilWell Cannabis
810 Richmond Avenue, Houston, TX 77006
(832) 416-2816 | [email protected]
https://oilwellcbd.com/
Instagram: @oilwellcbd

Serving Fulton County, Illinois with the same integrity, transparency, and commitment that built our reputation in Houston.